Paul M Palevsky
Overview
Explore the profile of Paul M Palevsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
207
Citations
6540
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vijayan A, Heung M, Awdishu L, Babroudi S, Green G, Koester L, et al.
J Am Soc Nephrol
. 2025 Feb;
PMID: 40014384
No abstract available.
2.
3.
Prasad A, Palevsky P, Bansal S, Chertow G, Kaufman J, Kashani K, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
1(6):100445.
PMID: 39132354
Patients with chronic kidney disease (CKD) are at an increased risk of developing cardiovascular disease (CVD), whereas those with established CVD are at risk of incident or progressive CKD. Compared...
4.
Barry A, Helget L, Androsenko M, Wu H, Kramer B, Newcomb J, et al.
Arthritis Rheumatol
. 2024 Jun;
76(10):1552-1559.
PMID: 38925627
Objective: Initiating urate-lowering therapy (ULT) in gout can precipitate arthritis flares. There have been limited comparisons of flare risk during the initiation and escalation of allopurinol and febuxostat, administered as...
5.
Helget L, Davis-Karim A, ODell J, Mikuls T, Newcomb J, Androsenko M, et al.
Am J Kidney Dis
. 2024 Jun;
84(5):538-545.
PMID: 38906504
Rationale & Objective: We conducted a prespecified examination of the efficacy and safety of allopurinol and febuxostat administered using a treat-to-target strategy in trial participants with chronic kidney disease (CKD)....
6.
Nikravangolsefid N, Suppadungsuk S, Singh W, Palevsky P, Murugan R, Kashani K
J Crit Care
. 2024 Jun;
83:154845.
PMID: 38879964
Continuous kidney replacement therapy (CKRT) is commonly used to manage critically ill patients with severe acute kidney injury. While recent trials focused on the correct dosing and timing of CKRT,...
7.
Palevsky P, Shreve S, Wong S
Ann Palliat Med
. 2024 May;
13(4):858-868.
PMID: 38735693
Advanced kidney disease is a progressive life-limiting illness associated with high symptom burden, disability, and highly intensive care near the end of life. There is growing interest in integrating palliative...
8.
Murugan R, Kashani K, Palevsky P
Intensive Care Med Exp
. 2024 Feb;
12(1):17.
PMID: 38376597
No abstract available.
9.
Wen Y, Su E, Xu L, Menez S, Moledina D, Obeid W, et al.
Sci Transl Med
. 2023 Dec;
15(726):eade7287.
PMID: 38091407
Acute kidney injury (AKI) is a major risk factor for long-term adverse outcomes, including chronic kidney disease. In mouse models of AKI, maladaptive repair of the injured proximal tubule (PT)...
10.
Murugan R, Boudreaux-Kelly M, Kellum J, Palevsky P, Weisbord S
Clin Kidney J
. 2023 Dec;
16(12):2626-2638.
PMID: 38046040
Background: Contrast-associated acute kidney injury (CA-AKI) has been associated with a higher risk of cardiovascular (CV) events. We studied the risk of CV events in chronic kidney disease (CKD) patients...